Brazil ANVISA Medical Device Recall October 2026: Rota-Strip, CLOSURERFS, and BD Catheters

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

Brazil ANVISA Medical Device Recall October 2026: Rota-Strip, CLOSURERFS, and BD Catheters

無料で聴く

ポッドキャストの詳細を見る

概要

Brazil's health authority, ANVISA, announced on October 23, 2026, the suspension and recall of several medical devices due to significant compliance failures. This episode details the specific products affected, including the Rota-Strip diagnostic test, the CLOSURERFS radiofrequency ablation stylet, and certain lots of the BD Angioccath catheter. We analyze the reasons behind each recall—from unsatisfactory test results to manufacturing non-compliance—and discuss the broader implications for manufacturers. The focus is on the critical importance of adhering to Good Manufacturing Practices (GMP) and maintaining a robust post-market surveillance system to ensure continued market access in Brazil. Key Questions: - What specific medical devices did ANVISA recall in its October 2026 announcement? - Why was the Rota-Strip diagnostic test suspended from the Brazilian market? - What manufacturing non-compliance led to the recall of Covidien's CLOSURERFS stylet? - Which lots of the BD Angioccath catheter were recalled and what was the associated risk? - What do these enforcement actions reveal about ANVISA's approach to post-market surveillance? - How does this event impact GMP requirements for medical device manufacturers in Brazil? - What are the essential components of an effective post-market surveillance plan for the Brazilian market? - What immediate, practical steps should regulatory and quality teams take in response to this news? Sources: - https://www.portal.afya.com.br/noticias/anvisa-suspende-e-recolhe-dispositivos-medicos-irregulares - https://conexaogeral.com.br/anvisa-suspende-teste-para-rotavirus-e-determina-recolhimento-de-dispositivos-medicos/ How Pure Global can help: Pure Global provides comprehensive regulatory consulting to help MedTech and IVD companies navigate complex markets like Brazil. Our experts offer end-to-end support, from developing a regulatory strategy and compiling technical dossiers to securing ANVISA registration and GMP certification. We also act as your Brazil Registration Holder and provide post-market surveillance services to ensure ongoing compliance. With our deep local expertise and advanced AI tools, we streamline the path to market access, helping you launch your products faster and maintain them compliantly. Contact us at info@pureglobal.com, visit https://pureglobal.com, or explore our free AI tools and database at https://pureglobal.ai.

まだレビューはありません